XML 43 R7.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net income $ 45,113 $ 42,786
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,758 4,734
Noncash stock-based compensation 84,270 71,941
Noncash change in fair value of equity securities 32 (174)
Noncash change in fair value of contingent consideration 2,486 0
Noncash impairment charges 2,910 0
Noncash operating lease expense 4,326 4,246
Deferred income taxes (6,280) 0
Amortization of deferred commissions cost 23,756 19,544
Changes in operating assets and liabilities:    
Trade accounts receivable, net (65,437) (20,676)
Operating lease liabilities (5,173) (3,827)
Other current assets and Other assets 436 1,970
Deferred commissions cost (29,532) (20,541)
Accounts payable (1,240) 108
Accrued liabilities 10,095 852
Deferred revenue 57,910 22,443
Other liabilities (3) 407
Net cash provided by operating activities 130,427 123,813
Cash flows from investing activities    
Purchase of property and equipment (2,973) (3,227)
Purchase of equity securities (788) (1,062)
Business combination, net of cash acquired (65,909) 0
Net cash used in investing activities (69,670) (4,289)
Cash flows from financing activities    
Repurchase of common stock (135,194) (133,655)
Proceeds from stock-based compensation plans 11,100 7,753
Net cash used in financing activities (124,094) (125,902)
Effects of exchange rate — changes in cash (5,842) 2,910
Net decrease in cash and cash equivalents (69,179) (3,468)
Cash and cash equivalents at beginning of period 312,754 287,778
Cash and cash equivalents at end of period 243,575 284,310
Supplemental disclosures of noncash activities    
Issuance of common stock for business combination 4,900 0
Operating lease liabilities arising from obtaining right-of-use assets $ 4,687 $ 5,493